Einrichtungen, die zum Universitätsklinikum Erlangen gehören

P130: Understanding the mechanism of nuclear envelope breakdown during NETosis July 1, 2023 - Dec. 31, 2024 Clinical traslatio of FLASHKNiFE, a promising device for ultrahigh dose-rate radiation therapy (FLASHKNiFE) (ST-EUC-EIT-09_FLASHKNiFE 2024) Jan. 1, 2024 - Dec. 31, 2024 Erarbeitung der Studienkonzeption, Medizinisch wissenschaftlich beratende Funktion (DiGA-Inkont) Digitale Gesundheitsanwendung zur Therapie von Inkontinenzpatienten Jan. 1, 2023 - Dec. 31, 2024 J093: Lipid mechanisms of drug instrumentalization: the role of serotonergic system Jan. 1, 2022 - Dec. 31, 2024 Metabolische Dysregulationen bei EMT-getriebener metastatischer Kolonisierung (A03) (SFB/TRR 305 A03) TRR 305: Über die Analyse der metastatischen Koloniebildung zu neuen systemischen Krebstherapien Jan. 1, 2021 - Dec. 31, 2024 Data entrepreneurs - a course for professionals (DECP) (PM-EUC-EIT-09_DECP 2024) Jan. 1, 2024 - Dec. 31, 2024 Identifizierung von molekularen Ursachen hypoxiebedingter orofazialer Spalten Dec. 1, 2023 - Nov. 30, 2024 J094: Decoding the effect of inflammatory bowel disease on microglia activation and synucleinopathy Dec. 1, 2021 - Nov. 30, 2024 Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. (HYPERBOOST) HYPERBOOST: Creation of advanced cancer treatment planning to boost the effect of Radiotherapy by combining with hyperthermia, heating the tumor. Dec. 1, 2020 - Nov. 30, 2024 Development and investigation of isotope-labelled antagonists for the orexin 1 receptor (OX1R) with subtype selectivity over OX2R July 1, 2020 - Nov. 30, 2024